When more isn't merrier: pharmaceutical alliance networks and breakthrough innovation

被引：15

作者：

Dong, John Qi ^{[1
]}

McCarthy, Killian J. ^{[1
]}

机构：

[1] Univ Groningen, Fac Econ & Business, NL-9747 AE Groningen, Netherlands

来源：

DRUG DISCOVERY TODAY | 2019年 / 24卷 / 03期

关键词：

DRUG DISCOVERY; STRATEGIC ALLIANCES; COLLABORATION;

D O I：

10.1016/j.drudis.2019.01.002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Strategic alliances, in particular strategic alliances with universities, are widely thought to be beneficial to the drug discovery process. However, the discussion of alliances and their effect has tended to focus on single alliances and has ignored the fact that firms tend to participate in multiple alliances simultaneously. Here, we show the importance of adopting a portfolio perspective of strategic alliances. We build a model of the U.S. pharmaceutical industry, and show how 2298 alliances, announced over a 15-year period, impact the alliance portfolios of 324 pharmaceutical firms, and how that, in turn, impacts the breakthrough innovations that these firms produce. In doing so, we show the stengths and benifits of strategic alliances, but we also show the dangers of adopting a more the merrier approach to strategic alliance making.

引用

页码：673 / 677

页数：5

共 19 条

[11] Success rates for strategic alliances - are they good enough? [J].

Grindley, JN .

DRUG DISCOVERY TODAY, 1998, 3 (04) :145-146

[12] Strategic alliances and market risk [J].

Havenaar, Matthias ;

Hiscocks, Peter .

DRUG DISCOVERY TODAY, 2012, 17 (15-16) :824-827

[13]

Hill CWL, 2003, ACAD MANAGE REV, V28, P257

[14] Organizational Social Network Research: Core Ideas and Key Debates [J].

Kilduff, Martin ;

Brass, Daniel J. .

ACADEMY OF MANAGEMENT ANNALS, 2010, 4 :317-357

[15] Knowledge, Networks, and Knowledge Networks: A Review and Research Agenda [J].

Phelps, Corey ;

Heidl, Ralph ;

Wadhwa, Anu .

JOURNAL OF MANAGEMENT, 2012, 38 (04) :1115-1166

[16] The technological origins of radical inventions [J].

Schoenmakers, Wilfred ;

Duysters, Geert .

RESEARCH POLICY, 2010, 39 (08) :1051-1059

[17] Models for open innovation in the pharmaceutical industry [J].

Schuhmacher, Alexander ;

Germann, Paul-Georg ;

Trill, Henning ;

Gassmann, Oliver .

DRUG DISCOVERY TODAY, 2013, 18 (23-24) :1133-1137

[18] Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare [J].

Wellenreuther, Ruth ;

Keppler, Dietrich ;

Mumberg, Dominik ;

Ziegelbauer, Karl ;

Lessl, Monika .

DRUG DISCOVERY TODAY, 2012, 17 (21-22) :1242-1248

[19] Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective [J].

Williams, Robert J. ;

Walker, Ian ;

Takle, Andrew K. .

DRUG DISCOVERY TODAY, 2012, 17 (5-6) :185-187

← 1 2 →